Liver transplantation for liver cancer in the era of immunotherapy
DOI:10.3969/j.issn.1001-5256.2021.02.001
- VernacularTitle:免疫治疗时代下的肝癌肝移植
- Author:
Zhao LI
1
;
Jiye ZHU
Author Information
1. Department of Hepatobilliary Surgery, Peking University People’s Hospital, Peking University Institute of Organ Transplantation, Beijing 100044, China
- Publication Type:Research Article
- Keywords:
Liver Neoplasms;
Liver Transplantation;
Immunotherapy
- From:
Journal of Clinical Hepatology
2021;37(2):249-252
- CountryChina
- Language:Chinese
-
Abstract:
Most patients with liver cancer in China cannot get radical surgical treatment at the time of diagnosis, and the breakthrough of immunotherapy for liver cancer in recent years has brought new hope to the patients with advanced liver cancer. In the field of liver transplantation for liver cancer, immunotherapy has attracted much attention because of its dual role in tumor immunity and transplantation immunity. There are also innovative applications of immunotherapy in preoperative down-staging treatment and the treatment of tumor recurrence after transplantation. In the era of immunotherapy, how to apply the thinking of transplant oncology to benefit liver cancer patients undergoing liver transplantation is a brand-new topic, and this requires multidisciplinary collaboration in clinical practice to explore the best treatment strategies for liver cancer patients undergoing liver transplantation and finally improve the prognosis of patients with advanced liver cancer.
